Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $13K invested in Revelation Biosciences Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
6% less capital invested
Capital invested by funds: $13.8K → $13K (-$820)
8% less funds holding
Funds holding: 12 → 11 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
120.33% less ownership
Funds ownership: 120.33% → 0% (-120%)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$402 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$61 |
| 3 |
CS
Clear Street
New York
|
-$2 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$2 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $3.91K | – | – | – |
|
|
CS
2
Clear Street
New York
| $3.09K | -$2 | -150 | -0.1% |
|
|
PVI
3
Pine Valley Investments
Marlton,
New Jersey
| $2.58K | – | – | – |
|
|
4
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.29K | -$2 | -150 | -0.2% |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| $684 | – | – | – |
|
6
Jane Street
New York
| $580 | – | – | – |
|
|
SIA
7
Soltis Investment Advisors
St. George,
Utah
| $499 | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $321 | -$61 | -4,250 | -12% |
|
|
9
UBS Group
Zurich,
Switzerland
| $12 | -$2 | -167 | -13% |
|
|
PIS
10
POM Investment Strategies
Raleigh,
North Carolina
| $11 | – | – | – |
|
|
QWM
11
Quaker Wealth Management
Moorestown,
New Jersey
| $5 | – | – | – |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$402 | -33,468 | Closed |
|
REVBW Hedge Fund Activity: Q3 2025 in Review
11 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2025, worth a combined $13K — down 5.9% from $13.8K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of REVBW and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $402 sold.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2025, down from 12 in Q2 2025.
- Funds reported $13K of Revelation Biosciences Warrant stock for Q3 2025, down 5.9% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences Warrant positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest Revelation Biosciences Warrant seller in Q3 2025 was Susquehanna International Group, an estimated $402 sold.
Based on aggregated 13F filings for Q3 2025.